BACKGROUND. Specific mutations of the p53 tumor suppressor gene in hepatocellular carcinoma (HCC) have been reported from several parts of the world, but to the authors' knowledge to date the status of this gene has not been studied in HCC patients in India, where HCC is one of the major cancers and
Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA
โ Scribed by Myung-Soo Kang; Hong-Joo Lee; Jae-Ho Lee; Ja-Lok Ku; Kathreen P. Lee; Michael J. Kelley; Yong-Jin Won; Soo-Tae Kim; Jae-Gahb Park
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 563 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background. The previous findings that sublethal damage repair (SLDR) capacity varies between carcinoma cell lines and that the inherent radiosensitivity of these lines tends to be higher in connection with p53 mutations lead us to study the possible role of p53 gene in the regulation of SLDR. The a
## Background: A critical factor for successful organ preservation treatment in head and neck cancer may be selecting tumors that respond to chemotherapy and radiation. previous results in patients indicated that tumors that overexpressed p53 were more sensitive to chemotherapy than those that did
We screened 29 human esophageal squamous cell carcinoma (ESC) cell lines for mutations of the p53 gene through all coding exons and exon-intron junctions. Mutations were found in 22 cell lines (76%), consisting of 20 single-base substitutions, 2 small deletions and I single-base insertion. Out of 20